Barone C - Search Results

1

Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer?

Rossi S, Basso M, Strippoli A, Schinzari G, D'Argento E, Larocca M, Cassano A, Barone C. Rossi S, et al. Among authors: barone c. Clin Colorectal Cancer. 2017 Dec;16(4):264-274. doi: 10.1016/j.clcc.2017.03.015. Epub 2017 Mar 24. Clin Colorectal Cancer. 2017. PMID: 28412137 Review.

2

Hormone Receptor Status and HER2 Expression in Primary Breast Cancer Compared With Synchronous Axillary Metastases or Recurrent Metastatic Disease.

Rossi S, Basso M, Strippoli A, Dadduzio V, Cerchiaro E, Barile R, D'Argento E, Cassano A, Schinzari G, Barone C. Rossi S, et al. Among authors: barone c. Clin Breast Cancer. 2015 Oct;15(5):307-12. doi: 10.1016/j.clbc.2015.03.010. Epub 2015 Mar 25. Clin Breast Cancer. 2015. PMID: 25922284 Review.

3

KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study.

Dadduzio V, Basso M, Rossi S, Cenci T, Capodimonti S, Strippoli A, Orlandi A, Cerchiaro E, Schinzari G, Cassano A, Martini M, Barone C. Dadduzio V, et al. Among authors: barone c. Mol Diagn Ther. 2016 Feb;20(1):65-74. doi: 10.1007/s40291-015-0178-8. Mol Diagn Ther. 2016. PMID: 26610798

4

Maintenance hormonal and chemotherapy treatment in metastatic breast cancer: a systematic review.

Rossi S, Schinzari G, Basso M, Strippoli A, Dadduzio V, D'Argento E, Cassano A, Barone C. Rossi S, et al. Among authors: barone c. Future Oncol. 2016 May;12(10):1299-307. doi: 10.2217/fon-2015-0065. Epub 2016 Mar 21. Future Oncol. 2016. PMID: 26996100 Review.

5

ERCC1 expression affects outcome in metastatic pancreatic carcinoma treated with FOLFIRINOX: A single institution analysis.

Strippoli A, Rossi S, Martini M, Basso M, D'Argento E, Schinzari G, Barile R, Cassano A, Barone C. Strippoli A, et al. Among authors: barone c. Oncotarget. 2016 Jun 7;7(23):35159-68. doi: 10.18632/oncotarget.9063. Oncotarget. 2016. PMID: 27147577 Free PMC article.

6

Is there a role for IGF1R and c-MET pathways in resistance to cetuximab in metastatic colorectal cancer?

Inno A, Di Salvatore M, Cenci T, Martini M, Orlandi A, Strippoli A, Ferrara AM, Bagalà C, Cassano A, Larocca LM, Barone C. Inno A, et al. Among authors: barone c. Clin Colorectal Cancer. 2011 Dec;10(4):325-32. doi: 10.1016/j.clcc.2011.03.028. Epub 2011 May 11. Clin Colorectal Cancer. 2011. PMID: 21729677

7

Schedule-dependent activity of 5-fluorouracil and irinotecan combination in the treatment of human colorectal cancer: in vitro evidence and a phase I dose-escalating clinical trial.

Barone C, Landriscina M, Quirino M, Basso M, Pozzo C, Schinzari G, Di Leonardo G, D'Argento E, Trigila N, Cassano A. Barone C, et al. Br J Cancer. 2007 Jan 15;96(1):21-8. doi: 10.1038/sj.bjc.6603496. Epub 2006 Dec 12. Br J Cancer. 2007. PMID: 17164761 Free PMC article. Clinical Trial.

8

Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases.

Barone C, Nuzzo G, Cassano A, Basso M, Schinzari G, Giuliante F, D'Argento E, Trigila N, Astone A, Pozzo C. Barone C, et al. Br J Cancer. 2007 Oct 22;97(8):1035-9. doi: 10.1038/sj.bjc.6603988. Epub 2007 Sep 25. Br J Cancer. 2007. PMID: 17895897 Free PMC article. Clinical Trial.

9

Trans-Arterial Chemoembolization with Irinotecan-Loaded Drug-Eluting Beads (DEBIRI) and Capecitabine in Refractory Liver Prevalent Colorectal Metastases: A Phase II Single-Center Study.

Iezzi R, Marsico VA, Guerra A, Cerchiaro E, Cassano A, Basso M, Devicienti E, Rodolfino E, Barone C, Bonomo L. Iezzi R, et al. Among authors: barone c. Cardiovasc Intervent Radiol. 2015 Dec;38(6):1523-31. doi: 10.1007/s00270-015-1080-9. Epub 2015 Mar 24. Cardiovasc Intervent Radiol. 2015. PMID: 25799948 Clinical Trial.

10

Different EGFR Gene Mutations in Exon 18, 19 and 21 as Prognostic and Predictive Markers in NSCLC: A Single Institution Analysis.

Rossi S, D'Argento E, Basso M, Strippoli A, Dadduzio V, Cerchiaro E, Martini M, Cassano A, Barone C. Rossi S, et al. Among authors: barone c. Mol Diagn Ther. 2016 Feb;20(1):55-63. doi: 10.1007/s40291-015-0176-x. Mol Diagn Ther. 2016. PMID: 26645830

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

609 results

Search Page